KSPHF
Price:
$23.229
Market Cap:
$166.30B
Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for overactive bladder treatment; P-TOL chewable tablets for treating hyperphosphatemia; and Minirin Melt OD tablets for nocturia due to nocturnal polyuria in males, central diabetes insipidus, and nocturnal enuresis resulted from decrease of urine osmolality. Its products in pipeline include KPS-0373 that has completed Phase III clinical tri...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-03-17
Stock Exchange
PNK
Ticker
KSPHF
According to Kissei Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 12.42. This represents a change of -28.09% compared to the average of 17.27 of the last 4 quarters.
The mean historical PE Ratio of Kissei Pharmaceutical Co., Ltd. over the last ten years is 20.32. The current 12.42 PE Ratio has changed 6.01% with respect to the historical average. Over the past ten years (40 quarters), KSPHF's PE Ratio was at its highest in in the September 2019 quarter at 220.12. The PE Ratio was at its lowest in in the March 2015 quarter at -160.38.
Average
20.32
Median
16.96
Minimum
9.12
Maximum
46.12
Discovering the peaks and valleys of Kissei Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.55%
Maximum Annual PE Ratio = 46.12
Minimum Annual Increase = -57.85%
Minimum Annual PE Ratio = 9.12
Year | PE Ratio | Change |
---|---|---|
2024 | 14.05 | 21.47% |
2023 | 11.57 | 26.86% |
2022 | 9.12 | -57.85% |
2021 | 21.63 | -53.09% |
2020 | 46.12 | 83.55% |
2019 | 25.13 | 64.52% |
2018 | 15.27 | -16.92% |
2017 | 18.38 | 18.27% |
2016 | 15.54 | -41.09% |
2015 | 26.38 | 82.00% |
The current PE Ratio of Kissei Pharmaceutical Co., Ltd. (KSPHF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.58
5-year avg
20.50
10-year avg
20.32
Kissei Pharmaceutical Co., Ltd.’s PE Ratio is greater than CannAmerica Brands Corp. (-0.00), greater than Maple Leaf Green World Inc. (-3.86), greater than Ionic Brands Corp. (-0.00), greater than Isracann Biosciences Inc. (0), greater than Christina Lake Cannabis Corp. (6.07), greater than Entourage Health Corp. (-0.04), greater than Avicanna Inc. (-8.41), greater than Silver Spike Investment Corp. (11.17), greater than RAMM Pharma Corp. (-0.16), greater than Craftport Cannabis Corp. (-0.00), less than Collegium Pharmaceutical, Inc. (21.76), less than Phibro Animal Health Corporation (30.69), greater than ANI Pharmaceuticals, Inc. (-55.72), greater than Procaps Group S.A. (2.40), greater than Acacia Diversified Holdings, Inc. (0), greater than THC Therapeutics, Inc. (-0.02), greater than Sunshine Biopharma, Inc. (-0.20), greater than Vext Science, Inc. (-0.66), greater than SLANG Worldwide Inc. (-0.04), greater than Amphastar Pharmaceuticals, Inc. (8.36), greater than Eagle Pharmaceuticals, Inc. (0.70), less than Alkermes plc (14.57), greater than Evolus, Inc. (-11.26),
Company | PE Ratio | Market cap |
---|---|---|
-0.00 | $704.00 | |
-3.86 | $712.65K | |
-0.00 | $584.47K | |
0 | $1.99M | |
6.07 | $6.98M | |
-0.04 | $1.23M | |
-8.41 | $22.81M | |
11.17 | $66.72M | |
-0.16 | $15.16M | |
-0.00 | $1.90M | |
21.76 | $965.55M | |
30.69 | $976.66M | |
-55.72 | $1.30B | |
2.40 | $113.95M | |
0 | $5.43K | |
-0.02 | $12.07K | |
-0.20 | $6.83M | |
-0.66 | $20.45M | |
-0.04 | $579.13K | |
8.36 | $1.17B | |
0.70 | $25.14M | |
14.57 | $5.19B | |
-11.26 | $640.57M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kissei Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kissei Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Kissei Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Kissei Pharmaceutical Co., Ltd. (KSPHF)?
What is the highest PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF)?
What is the 3-year average PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF)?
What is the 5-year average PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF)?
How does the current PE Ratio for Kissei Pharmaceutical Co., Ltd. (KSPHF) compare to its historical average?